What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

from Medical News Podcast · host PeerDirect Publishing

Drs. Waks and Lynce review the PATINA trial, which showed that adding a CDK4/6 inhibitor to HER2-targeted and endocrine therapy improved progression-free survival in triple-positive breast cancer, shaping how this subgroup may be managed.

Episode metadata supplied by the publisher feed · Published Oct 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

0:00 9:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 9 minutes long.

When was this Medical News Podcast episode published?

This episode was published on October 29, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!